Talisay Jr, Eusebio F.

HRN: 29-34-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/23/2026
07/30/2026
IV
600mg
Q6
Cellulitis
Remove - Pending Acceptance
07/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/23/2026
07/23/2026
IV
4.5g
LD
CAP MR, Cellulitis
Remove - Pending Acceptance
07/23/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/23/2026
07/30/2026
IV
2.25mg
Q6
CAP MR; CELLULITIS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: